Skip to main content
Erschienen in: Reactions Weekly 1/2018

01.08.2018 | Case report

Eculizumab

Fulminant meningococcal sepsis: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2018

Einloggen, um Zugang zu erhalten

Excerpt

A 25-year-old man developed fulminant meningococcal sepsis during treatment with eculizumab for paroxysmal nocturnal haemoglobinuria [dosage and duration of treatment to reaction onset not stated]. …
Literatur
Zurück zum Zitat Hall V, et al. Fulminant meningococcal sepsis due to non-groupable Neisseria meningitidis in a patient receiving eculizumab. Medical Journal of Australia 208: 478-479, No. 11, 18 Jun 2018. Available from: URL: http://doi.org/10.5694/mja17.01012 - Australia Hall V, et al. Fulminant meningococcal sepsis due to non-groupable Neisseria meningitidis in a patient receiving eculizumab. Medical Journal of Australia 208: 478-479, No. 11, 18 Jun 2018. Available from: URL: http://​doi.​org/​10.​5694/​mja17.​01012 - Australia
Metadaten
Titel
Eculizumab
Fulminant meningococcal sepsis: case report
Publikationsdatum
01.08.2018
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2018
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-018-49977-3

Weitere Artikel der Ausgabe 1/2018

Reactions Weekly 1/2018 Zur Ausgabe

Case report

Metformin